University of Oxford - Target Discovery Institute

The Target Discovery Institute (or TDI) is a new research centre initiated by the Nuffield Department of Medicine and the University of Oxford with a mandate to develop new target screening methodologies, investigate disease pathways as a means for identifying 'drug targets' and advance therapeutically relevant targets for drug development.  The centre is located on the Churchill Hospital campus at the Wellcome Trust Centre for Human Genetics and brings together the scientific expertise of several university partners including the Nuffield Department of Medicine, the Department of Cardiovascular Medicine, Department of Radiation Oncology and Biology, the Structural Genomics Consortium, the Department of Chemistry and the Oxford branch of the Ludwig Institute for Cancer Research to advance target discovery.  In addition, the TDI has fostered close collaborations with pharmaceutical and industrial companies broadening our expertise and linking academic research with industrial processes for drug development.

---